Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rosalba Minelli

Showing results (21-30 of 35) with videos related to

Pageof 4
Sort By:
Journal of Biomedical Nanotechnology|October 30, 2015
Improved Anti-Tumoral Therapeutic Efficacy of 4-Hydroxynonenal Incorporated in Novel Lipid Nanocapsules in 2D and 3D ModelsStefania Pizzimenti, Martina Daga, Eric Ciamporcero, et al.
Nature Communications|November 14, 2019
ZEB1/NuRD complex suppresses TBC1D2b to stimulate E-cadherin internalization and promote metastasis in lung cancerRoxsan Manshouri, Etienne Coyaud, Samrat T Kundu, et al.
Science Translational Medicine|March 15, 2019
ZEB1 suppression sensitizes KRAS mutant cancers to MEK inhibition by an IL17RD-dependent mechanismDavid H Peng, Samrat T Kundu, Jared J Fradette, et al.
Biorxiv : the Preprint Server for Biology|February 3, 2025
Adaptive Plasticity Tumor Cells Modulate MAPK-Targeting Therapy Response in Colorectal CancerOscar E Villarreal, Yixin Xu, Ha Tran, et al.
Cancer Research|September 8, 2019
Predictive Signatures Inform the Effective Repurposing of Decitabine to Treat KRAS-Dependent Pancreatic Ductal AdenocarcinomaCarla Mottini, Hideo Tomihara, Diego Carrella, et al.
Cancer Cell|October 7, 2015
The Genomic Landscape and Clinical Relevance of A-to-I RNA Editing in Human CancersLeng Han, Lixia Diao, Shuangxing Yu, et al.
Nature Communications|January 26, 2016
Functional annotation of rare gene aberration drivers of pancreatic cancerYiu Huen Tsang, Turgut Dogruluk, Philip M Tedeschi, et al.
Cancer Research|March 5, 2015
Genetic events that limit the efficacy of MEK and RTK inhibitor therapies in a mouse model of KRAS-driven pancreatic cancerPiergiorgio Pettazzoni, Andrea Viale, Parantu Shah, et al.
The Journal of Clinical Investigation|February 10, 2015
Lysyl hydroxylase 2 induces a collagen cross-link switch in tumor stromaYulong Chen, Masahiko Terajima, Yanan Yang, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 15, 2023
SMARCB1 regulates the hypoxic stress response in sickle cell traitMelinda Soeung, Luigi Perelli, Ziheng Chen, et al.
Pageof 4

Showing results (21-30 of 35) with videos related to

Sort By:
Pageof 4
Journal of Biomedical Nanotechnology|October 30, 2015
Improved Anti-Tumoral Therapeutic Efficacy of 4-Hydroxynonenal Incorporated in Novel Lipid Nanocapsules in 2D and 3D ModelsStefania Pizzimenti, Martina Daga, Eric Ciamporcero, et al.
Nature Communications|November 14, 2019
ZEB1/NuRD complex suppresses TBC1D2b to stimulate E-cadherin internalization and promote metastasis in lung cancerRoxsan Manshouri, Etienne Coyaud, Samrat T Kundu, et al.
Science Translational Medicine|March 15, 2019
ZEB1 suppression sensitizes KRAS mutant cancers to MEK inhibition by an IL17RD-dependent mechanismDavid H Peng, Samrat T Kundu, Jared J Fradette, et al.
Biorxiv : the Preprint Server for Biology|February 3, 2025
Adaptive Plasticity Tumor Cells Modulate MAPK-Targeting Therapy Response in Colorectal CancerOscar E Villarreal, Yixin Xu, Ha Tran, et al.
Cancer Research|September 8, 2019
Predictive Signatures Inform the Effective Repurposing of Decitabine to Treat KRAS-Dependent Pancreatic Ductal AdenocarcinomaCarla Mottini, Hideo Tomihara, Diego Carrella, et al.
Cancer Cell|October 7, 2015
The Genomic Landscape and Clinical Relevance of A-to-I RNA Editing in Human CancersLeng Han, Lixia Diao, Shuangxing Yu, et al.
Nature Communications|January 26, 2016
Functional annotation of rare gene aberration drivers of pancreatic cancerYiu Huen Tsang, Turgut Dogruluk, Philip M Tedeschi, et al.
Cancer Research|March 5, 2015
Genetic events that limit the efficacy of MEK and RTK inhibitor therapies in a mouse model of KRAS-driven pancreatic cancerPiergiorgio Pettazzoni, Andrea Viale, Parantu Shah, et al.
The Journal of Clinical Investigation|February 10, 2015
Lysyl hydroxylase 2 induces a collagen cross-link switch in tumor stromaYulong Chen, Masahiko Terajima, Yanan Yang, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 15, 2023
SMARCB1 regulates the hypoxic stress response in sickle cell traitMelinda Soeung, Luigi Perelli, Ziheng Chen, et al.
Pageof 4